Clinical Trials
Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma
In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted...
Drug Research
Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs
In a recent move, Hengrui Pharma and GSK have inked an agreement when it comes to the development of almost 12 innovative medicines throughout several...
Drug Research
Magnetic Particles Steer the Vesicles for Drug Delivery
Researchers have gone on to demonstrate that microscopic drug delivery containers can get magnetically steered to their objectives, thereby advancing the development when it comes...
BioPharma
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
Clinical Trials
UK government, Manufacturing, Investment, Clinical trials
The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy.
In...
Clinical Trials
AI in Alzheimer Drug Development to Enhances Clinical Trials
Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical...
Clinical Trials
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.